Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya | MicrobiomeTrials← Back to trialsNCT07545746
Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-07Est. Completion: 2027-09
Enrollment target: 140 participants Locations- Maseno University, Kisumu, Kenya
- Nyanza Reproductive Health Society, Kisumu, Kenya
Other microbiome trials you might be interested in
HIV InfectionsAdherence, Medication
The investigators will implement a 24-month fractional factorial design study (Aim 1). The investigators will recruit 51…
Cape Town, South AfricaEst. completion May 28, 2026
HIV-1-infection
The goal of this clinical study is to provide continued access to the study drug(s) to children and adolescents with hum…
Buenos Aires, ArgentinaEst. completion Mar 2034
Recruiting
Substance Use DisordersHIV Infections
This is a multi-phased study, funded through a National Institute on Drug Abuse (NIDA) K24 grant that aims to ultimately…
Charleston, United StatesEst. completion Aug 31, 2026